
    
      The duration and the injection timing of G-CSF are effective in the prevention of
      neutropenia, incidence of infection and non hematologic toxicity. With the TAC chemotherapy
      after resection of breast cancer, the G-CSF early injection versus late injection could
      change the frequency of neutropenia.
    
  